2024 annual financial data
Mereo BioPharma Group 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -47,364,000 USD and net income was -43,253,000 USD.
Operating cash flow was -32,834,000 USD.
Get free Mereo BioPharma Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -47,364,000 USD
- Net income
- -43,253,000 USD
- Operating cash flow
- -32,834,000 USD